Skip to content

SIGA Technologies SIGA Total costs & expenses

Total costs & expenses at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$145.6M-15.5%
Opko Health logo
Opko HealthOPK
$175.21M-19.3%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's total costs & expenses?
SIGA Technologies (SIGA) reported total costs & expenses of $11.56M in Q1 2026.
How has SIGA Technologies's total costs & expenses changed year-over-year?
SIGA Technologies's total costs & expenses increased by 24.4% year-over-year, from $9.3M to $11.56M.
What is the long-term trend for SIGA Technologies's total costs & expenses?
Over 4 years (2021 to 2025), SIGA Technologies's total costs & expenses has grown at a 12.3% compound annual growth rate (CAGR), from $44.58M to $70.87M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses the cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to assess the company's overall cost structure and operational efficiency in relation to its revenue generation.